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Title: Estimating the burden of COVID-19 on mortality, life expectancy and lifespan 
inequality in England and Wales: A population-level study 
 
Keywords: excess deaths, health inequality, infectious diseases, COVID-19 pandemic 
 
Abstract 
 
Objective: To determine the impact of the COVID-19 pandemic on mortality, life 
expectancy and lifespan inequality in the first half of 2020 (from week 1 to week 26 starting 
June 22) in England and Wales. 
 
Design: Demographic analysis of all-cause mortality from week 1 through week 26 of 2020 
using publicly available death registration data from the Office for National Statistics. 
 
Setting and population: England and Wales population by age and sex in 2020. 
 
Main outcome measure: Age and sex-specific excess mortality risk and deaths above a 
baseline adjusted for seasonality in the first half of 2020. We additionally provide estimates 
of life expectancy at birth and lifespan inequality defined as the standard deviation in age at 
death. 
 
Results: We estimate that there have been 53,937 (95% Prediction Interval: 53,092, 54,746) 
excess deaths in the first half of 2020, 54% of which occurred in men. Excess deaths 
increased sharply with age and men experienced elevated risks of death in all age groups. 
Life expectancy at birth dropped 1.7 and 1.9 years for females and males relative to the 2019 
levels, respectively. Lifespan inequality also fell over the same period. 
  
Conclusions: Quantifying excess deaths and their impact on life expectancy at birth provides 
a more comprehensive picture of the full COVID-19 burden on mortality. Whether mortality 
will return to - or even fall below - the baseline level remains to be seen as the pandemic 
continues to unfold and diverse interventions are put in place. 
 
Main text word count: 2,981 (excluding references) 
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Summary boxes: 
 
What is already known on this topic: COVID-19 related deaths may be misclassified as 
other causes of death thereby underestimating the full impact of the pandemic on mortality. 
Excess mortality, the difference between observed deaths and what would have been 
expected in the absence of the pandemic, is a useful metric to quantify the overall impact of 
the pandemic on mortality and population health. Life expectancy at birth and lifespan 
inequality assess the cumulative impact of the pandemic on population health. 
 
What this study adds: We examine death registration data from the Office for National 
Statistics from 2015 to week 26 (mid-year) in 2020 to quantify the impact of the COVID-19 
pandemic on mortality in England and Wales thus far. We estimate excess mortality risk by 
age and sex, and quantify the impact of excess mortality risk on excess deaths, life 
expectancy and lifespan inequality. During weeks 10 through 26 of 2020, elevated mortality 
rates resulted in 53,937 additional deaths compared with baseline mortality. Life expectancy 
at birth for males and females in the first half of 2020 was 78 and 81.8 years, which represent 
a decline of 1.9 and 1.7 years of life lost relative to the year 2019. Lifespan inequality, a 
measure of the spread or variation in ages at death, declined due to the increase of mortality 
at older ages.  
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Introduction 
 
Estimating the number of deaths caused by the coronavirus disease 2019 (COVID-19) is an 
important challenge [1]. Insufficient testing capacity for SARS-CoV-2 during the pandemic 
and misclassification of causes of death make the true toll of COVID-19 hard to estimate [2]. 
Moreover, the events and interventions that took place during the pandemic may have 
indirectly affected other causes of death [3]. For example, both fear of COVID-19 and the 
overstretching of the healthcare system may have deterred care-seeking for both chronic and 
acute conditions, potentially increasing mortality from other, non-COVID, causes[4]. 
Similarly, lockdown policies might have decreased deaths from external causes such as road 
traffic accidents, or increased deaths from causes such as suicide or related to domestic 
violence.  
 
Thus far, COVID-19 mortality in England and Wales has been tallied via confirmed or 
presumed deaths due to COVID-19, usually due to a positive SARS-CoV-2 test. An 
alternative approach to estimate the mortality burden of COVID-19 is to quantify the number 
of deaths during the pandemic compared to a baseline level of what would have been 
expected if the pandemic had not occurred. This approach for estimating excess all-cause 
mortality has been widely used to quantify the mortality toll of previous epidemics such as 
influenza[5] or HIV[6]. Excess mortality may be quantified in different ways and the excess 
numbers of deaths'' approach has been commonly used so far in England and Wales[7]. While 
this metric provides an important measure of the burden of the pandemic on a society, simply 
counting these excess deaths does not provide an understanding of the substantial variation 
by age and sex over time in elevated mortality risks[8,9], nor do excess deaths provide an 
understanding of the cumulative impact of the pandemic on life expectancy. Life expectancy 
at birth is a commonly used indicator of population health that expresses the average number 
of years a newborn is expected to live given the death rates in a particular period[10]. Life 
expectancy is sensitive to the ages at which deaths occur and can therefore shed additional 
light on the cumulative burden of COVID-19 on population health. Lifespan inequality is 
another complementary indicator of population health which has implications for public 
health planning. While life expectancy is a measure of average mortality, lifespan inequality 
is an indicator of the spread or variation in length of life (or conversely, ages at death). It is 
akin to the Gini Coefficient used by policymakers in understanding patterns of economic 
inequality. Lifespan inequality has important implications at both the individual and the 
societal level[11,12]. Greater lifespan inequality means that individuals face greater 
uncertainty about when they will die, potentially affecting decisions such as health 
behaviours over the life course[13]. Lifespan inequality also has important implications for 
health and social care planning and budgets, with higher levels implying greater dispersion in 
the ages at death and allocation of resources for different needs[11]. Lifespan inequality is 
one of the most fundamental measures of inequality that reflects how unevenly population 
health improvements are shared within a population[12].  
 
We estimate all-cause excess deaths from week 10 (March 2-8), the week in which the first 
death attributable to COVID-19 was registered in England and Wales, to week 26 of 2020 
(June 22-28). Week 26 marks the middle of the year 2020. We also provide estimates of life 
expectancy and lifespan inequality during the first 26 weeks of 2020 and compare them with 
previous trends. By considering all three measures together: excess deaths, life expectancy 
and lifespan inequality, the present study presents a comprehensive assessment of the 
mortality impacts of the COVID-19 pandemic thus far. 
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Methods 
 
Data 
 
We extracted all-cause death counts stratified by week of death registration, sex and 6 age-
groups (0-14, 15-44, 45-64, 65-74, 75-84 and 85-older years of age) from 2010 to week 26 of 
2020 from the Office for National Statistics (ONS) for England and Wales. We also obtained 
population estimates from ONS from 2010 to 2019[14], and population projections for 
2020[15]. As these projections represent the population at the mid-year point, we used 
standard interpolation techniques[16] to estimate weekly mean population by sex and age 
groups over the study period. Yearly death counts by 5-year age groups were used to 
calculate annual indicators[17] such as life expectancy and lifespan inequality. All analyses 
use publicly-available aggregated data. The population coverage of vital registration in 
England and Wales is complete. Between March and May 2020, 81.1% of all deaths and 
86.5% of deaths involving COVID-19 were registered within 1 week of occurrence[7]. Death 
registration in this period witnessed increased efficiency compared to trends noted in 
previous years due to changes implemented in the Coronavirus Act 2020 [18,19]. Based on 
trends from past years, 92% of deaths are registered within 1 month of occurrence.  
  
Excess mortality 
 
We estimated the baseline number of deaths in the absence of COVID-19 by fitting a 
Generalized Additive Model assuming a Poisson distribution of deaths during the period of 
study[20]. The model includes smooth effects for the long term trend, age and seasonality, 
and an interaction between age and seasonality (see Supplement section 1). The smoothed 
effects are stratified by sex. We then subtracted the expected number of deaths from the 
observed deaths for the period involving weeks 10 through week 26 of 2020, from March 2 to 
June 28, 2020.  
 
We fitted the model to the weekly deaths counts from January 4, 2010 to the week starting on 
March 2, 2020. This baseline was then projected forward until June 28, 2020 (week 26). 
Excess mortality is then defined as the observed weekly death count minus the baseline, 
summed across the pandemic period from March 2 to June 28, 2020. From this baseline, 95% 
predictive intervals were constructed by sampling death counts from a Poisson distribution. 
 
Demographic Methods  
 
Life expectancy and lifespan inequality by sex were estimated using the yearly death counts 
and population estimates for the years preceding 2020 using standard demographic 
techniques [10], from which 95% predictive intervals were generated[21]. For the first half of 
2020, death counts over the first 26 weeks were aggregated over age groups and death rates 
were calculated using half of the mid-year population estimate. 
 
Code and Data availability 
 
All analyses were carried out using R software[22]. All analysis scripts and data are available 
in a public repository[23].  
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Results 
 
Estimates of excess deaths 
 
We report results for the deaths that occurred above the age of 14 since estimates below this 
age fall within the predictive intervals of the model due to the small number of deaths 
occurring in this age group. 
 
The first death attributable to COVID-19 in England and Wales was registered in the week 
starting in March 2, 2020 (week 10). From that week to week 26, which ended on June 28, 
2020, there were 228,178 registered deaths over the age of 14, from which an estimated 
53,937 (53,092, 54,746) are excess mortality above the expected baseline (see Figure 1). This 
estimate represents a 31% (30.3, 31.5) increase in mortality compared to the expected level.  
 
 Death rates during the pandemic were consistently higher among males in all groups 
compared to females (see Supplement Figure 3). Male excess deaths accounted for 54% 
(28,889 deaths) of this total, compared to 46% (25,048 deaths) among females over the same 
period. These numbers are 28.7% (27.8, 29.5) and 33.2% (32.3, 34.1) higher, respectively, 
than the baseline. 
 
 
Figure 1. Cumulative excess deaths in England and Wales through the COVID-19 pandemic 
weeks 10-26 by sex. Shaded areas represent 95% prediction intervals. Excess deaths are 
defined as the total observed deaths subtracting the estimated baseline mortality.  
 
The 15 to 44 year old age group accounted for 290 (154, 418) excess deaths (6.1% (3.2, 9) 
above the expected level). For older age groups excess deaths rose sharply (see Figure 2). 
The toll of the pandemic resulted in 5,786 (5,504, 6,070) and 7,514 (7,176, 7,845) excess 
deaths among people between 45-64 and 64-74 years of age, respectively. These numbers are 
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28.4% (26.7,30.2) and 26.1% (24.7, 27.6) above the baseline. The largest numbers of lives 
lost were estimated among the groups 75-85 and 85 and older, with 29.1% (28, 30.3) and 
36.8% (35.8,37,9) above the expected mortality. Among the former, 15,091 (14,641, 15,547), 
excess deaths were estimated, while among the oldest age group there were 25,255 (24,720, 
25,768) deaths above the baseline. Note the larger number of female excess deaths in the 85+ 
group is due to there being 1.6 times more females in this age group compared to males. 
 
 
Figure 2. Cumulative excess deaths in England and Wales through the COVID-19  pandemic 
weeks 10-26 by sex and age groups. Shaded areas represent 95% prediction intervals. Excess 
deaths are defined as the total observed deaths subtracting the estimated baseline mortality.  
 
Estimates of life expectancy and lifespan inequality 
 
Life expectancy at birth increased from 81.4 (81.3-81.4) years in 2005 to 83.5 (83.5,83.6) 
years in 2019 for females in England and Wales. Similarly, male life expectancy increased 
from 77.1 (77.1,77.2) to 79.9 (79.8,79.9) years in the same period. Using data from the first 
26 weeks of 2020 yields an estimated life expectancy at birth of 81.8 (81.8,81.9) and 78.0 
(77.9,78.0) for females and males, respectively. A reduction of 1.7 year for females and 1.9 
years for males. 
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Figure 3 Life expectancy and lifespan inequality (standard deviation of ages at death) 
estimates for the periods 2001-2019, and for 2020 considering the first 26 weeks of the year 
by sex. Shaded areas represent 95% prediction intervals.  
 
From 2005 to 2019, lifespan inequality declined slowly from 13.8 (13.7, 13.9) to 13.5 
(13.4,13.6) years for females and from 15.0 (15.0, 15.1). to 14.7 (14.6, 14.7) years for males. 
In the first half of 2020, we estimate that lifespan inequality fell sharply to 12.9 (12.8,13.0) 
and 14.0 (13.9, 14.1) years for females and males, respectively, corresponding to a reduction 
of over six months for both sexes.  
 
We performed several sensitivity analyses. Firstly, we refitted the seasonal baseline without 
including the first 9 weeks of 2020. This adjustment did not have major effects on our 
estimates and by taking the first 9 weeks into account made our predictions in line with the 
observed trend in the beginning of the year. Secondly, we fitted a GAM model under the 
assumption of a Negative Binomial distribution and a Generalized Poisson Linear Model 
adjusted for year-to-year seasonality[24], also known as extended Serfling model[25] (see 
Supplement Section 1). Finally we created an empirical baseline by averaging the death rates 
observed in each week of the years 2015-2019 (see Supplement Figures 1 and 2). While these 
model variations produce central estimates of the number of excess deaths between 49,429 
and 58,982 depending on the choice of the model and its assumptions, they do not 
substantively affect the pattern of our results. For full details please see Supplement Tables 1 
and 2. In addition, we also estimated life expectancy using a piecewise constant hazard model 
and the results did not change. 
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Discussion 
 
Excess deaths during the first half of the year 2020 shed light on the cumulative burden of the 
COVID-19 pandemic in England and Wales. While several European countries have 
experienced substantially increased mortality over the course of the pandemic, data at hand 
suggests that England and Wales are amongst the worst performers in terms of excess deaths, 
especially in the working age group 15 to 64[26]. We estimated that 53,937 (53,092, 54,746) 
deaths would not have occurred in the absence of the pandemic. As previously noted by 
several studies, the toll of the pandemic had unequal impacts by age and sex in Europe and 
other regions[8,27,28]. Similarly, excess mortality varied between sexes, with males 
accounting for 54%. Excess deaths increased sharply over age and male deaths were 
estimated to exceed females in all age groups, with the exception of those above age 85. This 
is largely explained by the population composition of England and Wales where more 
females survive to higher ages. Excess risk of mortality was consistently higher among men 
in all ages groups (see Supplement Figure 3).  
 
Life expectancy in England and Wales had been steadily improving for 50 years before 
stagnating in the past decade [29,30]. We have provided estimates of life expectancy for 2019 
and the first half of 2020 which show that life expectancy dropped a staggering 1.7 and 1.9 
years for females and males respectively between these years. Moreover, our mid-2020 
estimates for life expectancy fall 1.7 and 2 years below the official projected life expectancy 
in 2020 for females and males[31], respectively. To put this into perspective, male and 
female life expectancy in the first half of 2020 regressed to the levels of 2008. It is likely that 
our estimates of excess deaths and life expectancy losses until this period are underestimated, 
as these estimates are based on deaths registered so far, a small fraction of which may have 
experienced registration delays[7]. Recent evidence suggests that reversals and stagnation in 
life expectancy amongst developed countries are usually a result of mid-life mortality crises 
[30]. In contrast, life expectancy losses during the pandemic have come about from sharp 
increases in older age mortality in both sexes. Trends across the second half of the year are 
unclear. Provided there is not a substantial second wave of COVID-19 and that the 
pandemic affected the most fragile individuals[32] (e.g. in the most deprived areas[33] and 
with pre-existing conditions[7]), the remaining population may see lower than usual death 
rates in the second half of 2020, thereby making the overall life expectancy losses less severe. 
However, even if death rates fall 10% below the baseline level, life expectancy for 2020 
would still be 4.4 and 6.6 months lower than expected for females and males. Alternatively, 
there could be long-term health effects among the millions of COVID-19 survivors that 
continue to impact future mortality risk[34]. For instance, if mortality declines but is still 
10% higher than the baseline death rates for the rest of the year, life expectancy losses would 
be around 1.3 and 1.6 years for females and males, respectively.  
 
Between March 1st and May 31st, 2020 there were 46,687 deaths involving COVID-19, 94% 
of which assigned COVID-19 as the underlying cause of death[18]. A sizable fraction of our 
estimate for excess deaths is thus likely to be directly linked to COVID-19. An additional 
2,924 deaths were noted where COVID-19 was involved, but not identified as the underlying 
cause of death. Deaths occurring from Alzheimer disease and dementia, ischemic heart 
disease, cerebrovascular diseases, neoplasm of the trachea, influenza and pneumonia and 
symptoms signs and ill-defined conditions category were all higher during the pandemic 
period. Together Alzheimer and symptom signs and ill-defined conditions experienced the 
largest increases in magnitudes compared to their size in previous years, and deaths occurring 
from asthma and diabetes at home also increased[18]. These preliminary cause-of-death 
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patterns indicate that a significant fraction of the unexplained mortality may be attributable to 
undiagnosed COVID-19. As new data become available over coming months, future research 
should seek to develop methods to disentangle excess deaths attributable to COVID-19 
versus those arising indirectly due to effects such as reduced care for other conditions.  
 
Historically, lifespan inequality has tended to fall as life expectancy has increased [28], 
although more recently, studies have found a reversed relationship with lifespan inequality 
increasing as life expectancy improves [11]. Our results show that life expectancy and 
lifespan inequality can indeed move in the same direction in periods of massive mortality 
stress such as during the pandemic. This effect has not been noted or documented elsewhere. 
While less inequality in lifespans is desirable in the context of life expectancy increases, here 
the high burden of mortality at working and older ages has contributed to lowering lifespan 
inequality at the expense of decreasing life expectancy, which is a failure. Whether lifespan 
inequality will increase or decrease over the next months, or years, will depend heavily on 
how mortality develops as the pandemic continues to unfold as well as the health and wider 
policy responses put in place by the government. 
 
Our results have important implications for health and social care planning in England and 
Wales. To return life expectancy to an increasing trend will require major efforts from a 
healthcare system weakened by the unfolding pandemic as well as sustained investment in 
wider societal policies driving population health. These include the high levels of inequality 
with respect to health and length of life[35] which have worsened in the past decade[36]. It is 
also likely that uneven demand for healthcare services[37] for the next months due to the 
pandemic will put additional pressure on healthcare systems. In the midst of this uncertainty 
these systems must begin to address the huge impact on hospital waiting lists of months of 
deferred treatments for chronic health conditions, as well as the huge drop off in referrals for 
routine care[38] and the longer-term consequences of the suspension of programmes such as 
routine cancer screening during the pandemic[39]. In this context, the potential impact of 
low-cost, non-pharmaceutical interventions, such as facemasks use[40] and social contact 
restrictions[41] to help reduce the number of future COVID-19 cases and deaths is of the 
highest importance. 
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Section 1. Estimation of the baseline mortality risk using 4 different approaches using 
training data from 2010 to week 10 of 2020 by age and sex.  
 
1. Generalized Additive Model assuming a Negative Binomial distribution to account for 
overdispersion of deaths during the period we study[1]. The model includes smooth effects 
for the long term trend, age and seasonality, and an interaction between age and seasonality. 
The smooth effects are stratified by sex. The basic structure of the model is as follows: 
 
log(ܧ( ௧ܻ)/Ʌ୲) = ߙ  + sex + ଵ݂(time௧) + ଶ݂(age௧) + ଷ݂(seasonality୲ ) + ସ݂(seasonality୲, age௧) 
 
Where ܧ( ௧ܻ) are the expected deaths in a given week, Ʌ୲ are the offset, ௜݂ are smooth 
functions. ଵ݂ and ଶ݂ are penalized splines for the long term trend and the age effect, 
respectively. ଷ݂ is a penalized cyclic spline for the seasonality and ସ݂ is a smooth interaction 
between age and seasonality.  
 
2. The second approach is a Generalized Additive Model assuming a Poisson distribution with 
the same structure as above.  
3. The third approach is a Generalized Linear Model assuming a Poisson distribution used to 
estimate baseline mortality during influenza epidemics and known as Serfling model[2,3]. 
The basic structure of the model is as follows: 
 
log(ܧ( ௧ܻ)/Ʌ୲) = ߙ  + ݐߚ  + ଶߛ  sin ൬2ݐߨ
52
൰ + ଷߛ cos ൬2ݐߨ
52
൰+ ସߛ  sin ൬2ݐߨ
26
൰ ହߛ + cos ൬2ݐߨ
26
൰ 
4. We constructed an empirical baseline mortality based on the average mortality rate over the 
previous five years 2015-19 within each week and stratum. The associated deaths from this 
approach result from multiplying the average death rates by the population exposed to the risk.  
 
Excess deaths produced with different models.  
 
Table 1. Excess deaths by the end of week 26 for ages 15 and above estimated with 4 different 
models with 95% predictive intervals in England and Wales.  
 
Model Excess deaths Lower bound Upper bound 
GAM- Negative Binomial 58,982 56,329 61,827 
GAM- Poisson 53,938 53,093 54,746 
GLM- Poisson 54,150 53,281 54,928 
Average Mortality 49,429 48,589 50,210 
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Table 2. Excess deaths by the end of week 26 for ages 15 and above estimated with 4 different 
models by age and sex with 95% predictive intervals in England and Wales.  
  Females  Males 
Model  
Age 
group 
Excess 
deaths 
Lower 
bound 
Upper 
bound   
Excess 
deaths 
Lower 
bound 
Upper 
bound 
GAM 
Negative 
Binomial 
15-44 198 95 304   216 53 379 
45-64 2,191 1,823 2,534  4,125 3,613 4,626 
65-74 3,026 2,504 3,532  5,286 4,591 5,993 
75-84 6,966 6,016 7,898  9,721 8,644 10,872 
85+ 15,870 14,217 17,485   11,383 10,232 12,456 
         
GAM 
Poisson 
15-44 135 57 214  155 44 259 
45-64 1,896 1,711 2,083  3,891 3,679 4,098 
65-74 2,587 2,380 2,785  4,928 4,670 5,203 
75-84 6,024 5,693 6,326  9,067 8,731 9,375 
85+ 14,408 13,995 14,808   10,848 10,489 11,167 
         
GLM 
Poisson 
15-44 113 32 187  93 -11 203 
45-64 2,020 1,833 2,192  3,786 3,588 3,992 
65-74 2,767 2,558 2,981  5,177 4,919 5,419 
75-84 7,038 6,752 7,348  9,722 9,413 10,031 
85+ 13,249 12,841 13,662   10,186 9,868 10,521          
Average 
Mortality 
15-44 89 7 170  55 -50 161 
45-64 1,781 1,601 1,953  3,473 3,248 3,702 
65-74 2,438 2,223 2,642  4,601 4,345 4,854 
75-84 5,923 5,618 6,228  8,482 8,169 8,807 
85+ 12,811 12,411 13,186   9,776 9,457 10,107 
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Figure 1. Expected (lines) vs Observed deaths (points) counts based on the 4 approaches 
described above for males by age groups (rows) 0-14, 15-44, 45-64, 65-74, 75-84 and 85-older 
years of age. 
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Figure 2. Expected (lines) vs Observed deaths (points) counts based on the 4 approaches described 
above for females by age groups (rows) 0-14, 15-44, 45-64, 65-74, 75-84 and 85-older years of age. 
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Figure 3. Sex ratio males/females of death rates during the course of the pandemic by age 
groups (rows) 0-14, 15-44, 45-64, 65-74, 75-84 and 85-older years of age. 
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